HIGHLIGHTS
- who: Inhibitors et al. from the Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China have published the research work: Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors, in the Journal: (JOURNAL)
- future: In-depth studies of the molecular interactions between tumors and immune cells have provided new prospects for tumor treatments.
SUMMARY
Cancer is a prevalent disease that threatens human health worldwide (Bray et_al, 2018). The immune escape of cancer cells is a significant challenge in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.